In discussing the impact of Covid-19 with healthcare professionals they are quick to highlight the positive changes the pandemic has provided for patient experience. Patients have adapted well to online and hybrid interactions with physicians, accelerating the move toward digital healthcare, including the adoption of advanced technology. This digital transformation offers pharma-marketeers the opportunity to use digital and social media intelligence to understand patients’ concerns directly, analysing data about how they are speaking about their medicines online, from social media platforms to gardening forums.
There is an irreversible trend towards digitisation within the industry, with patients and physicians communicating at a more hybrid level. The option for hybrid care allows the patient to choose how they communicate and access healthcare, offering greater choice and faster responses. It also provides actionable insights for those ad agencies which operate in the healthcare sector.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The Talking Medicines mission is to be the World’s Gold Standard for Patient Intelligence by Medicine.